Key Takeaways Lipedema is not regular obesity. It involves specific adipose tissue dysfunction, hormonal imbalances, and increased systemic inflammation. Tirzepatide’s dual GLP-1 and GIP receptors activation effects, fat metabolism promotion, inflammation reduction, and insulin sensitivity improvement could be advantageous for lipedema. Preliminary clinical data indicates tirzepatide promotes weight loss, metabolic health, and could present a […]